Potentiation of 3,4-methylenedioxymethamphetamine-induced dopamine release and serotonin neurotoxicity by 5-HT2 receptor agonists
- 1 November 1994
- journal article
- research article
- Published by Elsevier in European Journal of Pharmacology
- Vol. 264 (3) , 325-330
- https://doi.org/10.1016/0014-2999(94)90669-6
Abstract
No abstract availableKeywords
This publication has 25 references indexed in Scilit:
- Effects of enantiomers of MDA, MDMA and related analogues on [3H]serotonin and [3H]dopamine release from superfused rat brain slicesPublished by Elsevier ,2002
- Effect of acute monoamine depletion on 3,4-methylenedioxymethamphetamine-induced neurotoxicityPharmacology Biochemistry and Behavior, 1993
- 5-HT2 receptor-mediated potentiation of dopamine synthesis and central serotonergic deficitsEuropean Journal of Pharmacology, 1993
- A proposed new nomenclature for 5-HT receptorsTrends in Pharmacological Sciences, 1993
- Neuroanatomic specificity and time course of alterations in rat brain serotonergic pathways induced by MDMA (3,4‐methylenedioxymethamphetamine): Assessment using quantitative autoradiographySynapse, 1991
- Facilitation of dopamine release in vivo by serotonin agonists: studies with microdialysisEuropean Journal of Pharmacology, 1991
- Combined administration of a non-neurotoxic 3,4-methylenedioxymethamphetamine analogue with amphetamine produces serotonin neurotoxicity in ratsNeuropharmacology, 1991
- Enantiomeric differences in the effects of 3,4-methylenedioxymethamphetamine on extracellular monoamines and metabolites in the striatum of freely-moving rats: An in vivo microdialysis studyNeuropharmacology, 1990
- MDMA-induced neurotoxicity: Parameters of degeneration and recovery of brain serotonin neuronsPharmacology Biochemistry and Behavior, 1988
- Self-inhibition by Dopaminergic NeuronsScience, 1975